COLORADO SPRINGS, Colo., The Spectranetics Corporation today announced U.S. Food and Drug Administration (FDA) Premarket Notification 510(k) submission of the Bridge Occlusion Balloon. Building on the ...

Less than one out of every eight patients with infective endocarditis and a cardiac implantable electronic device (CIED) underwent recommended transvenous lead removal/extraction over a recent 4-year ...